Africa News Line

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer

africa-live — Thu, 21 May 2026 13:54:46 GMT

DARMSTADT, Germany - Thursday, 21. May 2026 Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media (BUSINESS WIRE) -- Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study assesses the efficacy and safety of Precem-TcT, alone or with bevacizumab, in patients with mCRC who are intolerant- or refractory-to, or progressed after, systemic therapies. The PROCEADE®-CRC-03 study will be conducted in approximately 165 sites in 20 countries and will recruit approximately 1,020 patients with mCRC. In Phase 1 (PROCEADE®-CRC-01; NCT05464030), Precem-TcT as monotherapy or in combination showed predictable and manageable safety in more than 100 patients with heavily pretreated mCRC. At the recommended dose for Phase 3 development (2.8 mg/kg Q3W; n=29), confirmed objective response rate (cORR) was 20.7% (95% CI: 8.0, 39.7), median PFS was 6.9 months (95% CI: 4.4, 9.5) and median OS was not reached (95% CI: 8.7, NE) after a median follow-up of 13.1 months. “The PROCEADE®-CRC-03 Phase 3 study is designed to address significant unmet needs for patients with metastatic colon cancer whose disease has progressed after standard therapies,” said Kanwal P.S. Raghav, MBSS, MD, Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, Houston. “The data from the phase 1 study suggested a manageable safety profile for Precem-TcT and encouraging early tumor response in the patients with heavily pre-treated metastatic colorectal cancer. CEACAM5 is largely absent from healthy tissues and is overexpressed in nearly all mCRC cases, supporting a non-selective, universal patient approach, and represents a promising therapeutic target in this setting.” Globally, CRC is the third-most commonly diagnosed malignancy and the second leading cause of cancer-related deaths.1 Merck chose mCRC as the first indication to assess the efficacy and safety of Precem-TcT because ~90% of colorectal cancers overexpress CEACAM5,2 and there is a high unmet clinical need in patients with metastatic colorectal cancer, especially among those who progressed on several previous therapies.3,4,5 Patients with advanced colorectal cancer typically face a challenging prognosis, with few options available for those whose disease continues to progress after three or more lines of therapy. Additionally, with progression, response to treatment and prognosis become increasingly worse over time. Advancing the Future of Cancer Care At Merck, we strive every day to improve the futures of people living with cancer. Building on our 350-year global heritage as pharma pioneers, we are focusing our most promising science to target cancer’s deepest vulnerabilities, pursuing differentiated molecules to strike cancer at its core. By developing new therapies that can help advance cancer care, we are determined to create a world where more cancer patients will become cancer survivors. Learn more at www.merckgroup.com. About Precemtabart tocentecan (M9140) Precemtabart tocentecan is an investigational anti-CEACAM5 antibody-drug conjugate (ADC). Leveraging the company’s novel linker-payload technology, precemtabart tocentecan is the first CEACAM5 ADC with an exatecan payload, a potent topoisomerase inhibitor (TOP1i), which has been rationally designed for stability in circulation and superior cancer cell killing activity. Beyond the direct effect on the target cell, precemtabart tocentecan has been shown in preclinical research to induce tumor cell death through a bystander effect in which exatecan permeates the cell membrane to neighboring cells, inducing apoptosis (cell death). This bystander effect within the tumor microenvironment may enhance efficacy. Precemtabart tocentecan is currently being evaluated across tumor types with CEACAM5 expression and a high unmet need, including metastatic colorectal cancer (mCRC), gastric cancer (GC), non-small cell lung cancer (NSCLC), and pancreatic ductal adenocarcinoma (PDAC). About Colorectal Cancer Colorectal cancer (CRC) is cancer of the colon or rectum, which often arises from benign polyps that eventually turn cancerous. It is the third most common diagnosed malignancy, and the second leading cause of cancer deaths worldwide with approximately 1 in 10 cancer deaths attributed to CRC. Despite new therapies, 5-year survival of stage 4 CRC is <20%. The global burden of CRC has substantially increased over time and is expected to increase by 60% to more than 2.2 million new cases and 1.1 million deaths by 2030.1 About Merck Merck, a leading science and technology company, operates across life science, healthcare and electronics. More than 62,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2025, Merck generated sales of € 21.1 billion in 65 countries. Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics. All Merck press releases are distributed by e-mail at the same time they become available on the Merck website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service. 1 World Health Organization Colorectal cancer: Key facts. Accessed 8 May 2026. https://www.who.int/news-room/fact-sheets/detail/colorectal-cancer. 2 Kopetz S BV, et al. M9140, a novel anti-CEACAM5 antibody–drug conjugate with a potent topoisomerase 1 inhibitor payload (exatecan): preclinical data and results from a phase 1 dose-escalation study in patients with metastatic colorectal cancer (PROCEADE-CRC-01). Nature Medicine. 2025. 3 Biller LH, Schrag D. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA. 2021;325(7):669-685. doi:10.1001/jama.2021.0106. 4 Xie Y-H, Chen Y-X, Fang J-Y. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduction and Targeted Therapy. 2020/03/20 2020;5(1):22. doi:10.1038/s41392-020-0116-z. 5 Martínez-Lago N, Chucla TC, De Castro BA, et al. Efficacy, safety and prognostic factors in patients with refractory metastatic colorectal cancer treated with trifluridine/tipiracil plus bevacizumab in a real-world setting. Scientific Reports. 2022/08/26 2022;12(1):14612. doi:10.1038/s41598-022-18871-9. View source version on businesswire.com: https://www.businesswire.com/news/home/20260521312109/en/ Permalink https://www.aetoswire.com/en/news/2105202655228 Contacts Sebastian Roos sebastian.roos@merckgroup.com Phone: +49 151 14 54 1721

BeOne Medicines Launches One Save Changes Everything, a Global Cancer Care Awareness Campaign with Soccer Legend Tim Howard

africa-live — Thu, 21 May 2026 10:16:58 GMT

SAN CARLOS, Calif. Campaign connects the preparation, precision, and grit that define great goalkeeping to the persistent scientific, clinical, and community efforts that drive progress in cancer care Features international goalkeepers, uniting soccer’s global reach with BeOne’s commitment to patients everywhere (BUSINESS WIRE)--BeOne Medicines Ltd. (“BeOne”) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today launched One Save Changes Everything, a campaign that uses soccer as a lens to recognize the scientific, clinical, and human moments that matter in cancer care. The campaign launches with goalkeeping legends, including former U.S. Men’s National Team goalkeeper Tim Howard. The initiative is backed by a $300,000 community commitment for the installation of soccer mini-pitches near cancer treatment centers with the U.S. Soccer Foundation, and BeOne colleague‑driven charitable support across the world. John V. Oyler, Co-Founder, Chairman, and CEO, BeOne Medicines, said: “Just like soccer is defined by save after save, progress in cancer is built moment by moment – in the lab, in the clinic, and in the communities where patients and families face it every day. ‘One Save Changes Everything’ was created to recognize the researchers who pursue targets others may have overlooked, the clinicians who act under pressure, the caregivers who show up without recognition, and the patients whose resilience fuels it all. BeOne was built for those moments: to be ready, to move with urgency, and to make sure progress reaches patients wherever they are. That belief drives everything we do.” A Personal Connection to Cancer A global soccer legend, Howard’s 16 saves against Belgium in 2014 – the most in international soccer history – are more than a record. They are the literal expression of the One Save Changes Everything campaign’s central belief: that preparation, presence, and the refusal to yield, applied moment after moment, can change the outcome of the most consequential events. Howard’s connection to the campaign runs deeper than the sport. When he was 11, his grandfather was diagnosed with cancer. The ordinary evenings that followed – shared dinners, quiet walks, simply being present – he now recognizes as some of these moments. Former U.S. Men’s National Team goalkeeper Tim Howard said: “The moments that matter most aren’t always the ones people see. When my grandfather was sick, what stuck with me was our family showing up for him – quietly, consistently, and when it counted. Watching them taught me that being present, prepared, and willing to act can change everything. Partnering with BeOne feels natural because that’s how they show up for patients: every day, around the world, when it counts.” Additional international goalkeepers will be announced to support the campaign alongside Tim Howard, along with voices from the cancer community that reflect BeOne’s global footprint. Turning Purpose into Action True to BeOne’s belief that purpose must translate into action, One Save Changes Everything extends beyond storytelling through a partnership with the U.S. Soccer Foundation. BeOne will fund the installation of soccer mini-pitches, creating spaces for movement, connection, and moments of normalcy for families affected by cancer. Ed Foster-Simeon, President & CEO, U.S. Soccer Foundation said: “Soccer has a unique ability to bring joy and connection in the most difficult moments. Placing mini-pitches near cancer centers creates permanent, accessible spaces for the families who need them most. We’re proud to partner with BeOne to create meaningful places for families to play.” BeOne Colleagues Join One Save Changes Everything BeOne’s more than 12,000 colleagues spanning six continents are the engine behind the donation commitment. For every hour an employee volunteers to support their community during the campaign period, BeOne will convert those hours into charitable dollars toward the $300,000 total to support the U.S. Soccer Foundation and other nonprofit organizations across the world. One Save Changes Everything launches around the world today. Learn more at BeOneSave.com. About BeOne Medicines BeOne Medicines is a global oncology company that is discovering and developing innovative treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The Company has a growing global team spanning six continents who are driven by scientific excellence and exceptional speed to reach more patients than ever before. To learn more about BeOne, please visit www.beonemedicines.com and follow us on LinkedIn, X, Facebook, and Instagram. About Tim Howard Tim Howard is one of the most accomplished goalkeepers in U.S. soccer history. He represented the U.S. Men’s National Team from 2002 to 2017 and set the FIFA World Cup record for most saves in a single match with 16 saves against Belgium in 2014 – a record that still stands. Howard played professionally for Manchester United, Everton, and the Colorado Rapids, among other clubs, over a career spanning more than two decades. He is currently a broadcaster and analyst and serves as the U.S. campaign partner for One Save Changes Everything. To access BeOne media resources, please visit our Newsroom. View source version on businesswire.com: https://www.businesswire.com/news/home/20260520118614/en/ Permalink https://www.aetoswire.com/en/news/2005202655189 Contacts Investor Contact Liza Heapes +1 857-302-5663 ir@beonemed.com Media Contact Kyle Blankenship + 1 667-351-5176 media@beonemed.com

EIG’s MidOcean Energy Announces $120m Investment from The Arab Energy Fund as Part of Equity Raise

africa-live — Thu, 21 May 2026 09:23:18 GMT

(BUSINESS WIRE) -- MidOcean Energy (“MidOcean” or the “Company”), a liquefied natural gas (LNG) company formed and managed by EIG, today announced a $120 million equity investment from The Arab Energy Fund (‘’TAEF’’), a leading multilateral impact financial institution, as part of its current equity capital raise.

TAEF’s investment further strengthens MidOcean’s high-quality investor base and underscores continued strong interest in the Company’s strategy to build a diversified, resilient and long-life global LNG business.

There is significant further momentum from additional investors currently in documentation, and MidOcean will continue to raise capital, with a cumulative target of up to $2 billion from new investors.

R. Blair Thomas, MidOcean Chairman and EIG CEO, said: “We are delighted to welcome The Arab Energy Fund as a shareholder in MidOcean. Their significant expertise in energy investments is a strong validation of MidOcean’s strategy to build a leading global LNG business. In parallel, EIG and TAEF are seeking collaboration opportunities across energy infrastructure in the Middle East, with the aim of further deepening our relationship.”

De la Rey Venter, CEO of MidOcean, said: “This investment supports our strategy of building a diversified LNG portfolio and positions us well to execute on our identified growth opportunities. We welcome TAEF with its more than 50 years of experience in energy investing and focus on energy security and sustainability.”

Khalid Al-Ruwaigh, CEO of The Arab Energy Fund, said: “Our investment in MidOcean Energy reflects the Fund’s commitment to supporting strategic energy platforms that contribute to global energy security and a more sustainable energy mix. LNG continues to play a critical role as a reliable and flexible energy source, and MidOcean’s disciplined approach and high-quality asset base align well with our long-term investment strategy. EIG is a great partner and we look forward to unlocking further value through collaboration across energy infrastructure, particularly in the Middle East.”

Important Notice

This announcement is for information purposes only and does not constitute an offer to sell or the solicitation of an offer to subscribe for or purchase any securities. Any offering will be made only pursuant to applicable offering documents and in compliance with applicable securities laws.

About EIG

EIG is a leading institutional investor in the global energy and infrastructure sectors with $25.9 billion assets under management as of March 31, 2026. EIG specializes in private investments in energy and energy-related infrastructure on a global basis. During its 44-year history, EIG has committed - $53.9 billion to the energy sector through 426 projects or companies in 44 countries on six continents. EIG’s clients include many of the leading pension plans, insurance companies, endowments, foundations and sovereign wealth funds in the U.S., Asia and Europe. EIG is headquartered in Washington, D.C. with offices in Houston, London, Sydney, Rio de Janeiro, Hong Kong and Seoul. For additional information, please visit www.eigpartners.com.

About MidOcean

MidOcean Energy, an LNG company formed and managed by EIG, seeks to build a diversified, resilient, cost- and carbon-competitive global LNG portfolio. It reflects EIG’s belief in LNG as a critical element of a lower carbon, competitive and more secure global energy system. MidOcean Energy has diverse LNG interests, including in LNG Canada, Gorgon LNG, Pluto LNG, QCLNG and Peru LNG. The company is headed by De la Rey Venter, a 30-year industry veteran who has held a variety of senior executive roles, including Global Head of LNG for Shell Plc. For additional information, please visit www.midoceanenergy.com.

About The Arab Energy Fund

The Arab Energy Fund (The Fund) is a multilateral impact financial institution focused on the MENA energy and utility sectors, established in 1974 by ten Arab oil-exporting countries. The Fund’s mission is to support the energy ecosystem with debt and equity solutions to enable energy security and sustainability and to develop local value chains and services in the MENA region. The Arab Energy Fund creates impact by contributing to economic prosperity and enabling local communities via talent development and knowledge creation. The Fund offers a comprehensive range of funding solutions across the entire energy value chain to leading public and private sector business partners in over 35 markets. The Arab Energy Fund applies best-practice ESG principles across all operations, with environmental and socially linked projects comprising c.20% of its USD 5.8bn loan portfolio. The Arab Energy Fund is the only energy-focused financial institution in the MENA region rated ‘Aa2’ by Moody’s, ‘AA+’ by Fitch and ‘AA-’ by S&P.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260520063539/en/

Permalink
https://www.aetoswire.com/en/news/2005202655199

Contacts
EIG/MidOcean Contact Information
FGS Global
Kelly Kimberly / Brandon Messina
+1 212-687-8080
EIG@fgsglobal.com

The Arab Energy Fund Contact Information
Communications Department
Yasa Ahmad
Yasa.Ahmad@edelmansmithfield.com

Nexo Championship Returns to Aberdeenshire as Nexo Expands DP World Tour Footprint

africa-live — Thu, 21 May 2026 07:42:38 GMT

VIRGINIA WATER, England - Wednesday, 20. May 2026

Nexo renews its Nexo Championship title partnership for the second year in 2026.
The Nexo Championship, with a newly increased prize fund of $3 million, will return to Aberdeenshire on August 20-23, 2026.
The tournament concludes the 2026 Closing Swing on the Race to Dubai schedule.

(BUSINESS WIRE) -- Nexo, the premier digital assets wealth platform, and the DP World Tour have confirmed a renewed agreement that will see the Nexo Championship return to Trump International Golf Links in Aberdeenshire from August 20-23, 2026. The tournament will serve as the concluding event of the DP World Tour’s Closing Swing – the final event of the first phase of the 2026 Race to Dubai.

In 2025, Nexo joined the DP World Tour as its Official Digital Wealth Platform through 2027 before soon adding the title rights at the Nexo Championship. For its part, the Nexo Championship made its mark from day one: The inaugural 2025 edition launched the Course Record presented by Nexo – a season-long rolling prize fund, starting at $10,000 per tournament and growing with each event until a course record is broken, before resetting for the next.

"The Nexo Championship has become something we are genuinely proud of – a tournament that launched the first-ever course record prize on the DP World Tour, and a Scottish champion on home soil in its inaugural year. We are back because this partnership earns its place in our portfolio through measurable long-term view. The Nexo Championship and the DP World Tour give us concentrated, recurring exposure to exactly the audience Nexo is built for – and that is a combination worth renewing,” the Nexo team said of the sponsorship.

Ben Cowen, Chief Tournament and Operations Officer at the DP World Tour, said: “We are pleased to have reached this new agreement with both Nexo and Trump International Golf Links for the Nexo Championship to again be part of our global schedule, and we thank them for their continued commitment. The Trump International Old Course has earned a reputation as one of the leading new links courses in the United Kingdom, and it was a great backdrop for last year’s tournament. With the Staysure PGA Seniors Championship taking place on our Staysure Legends Tour at the start of August, it is set to be another fantastic month of golf in Aberdeen this summer.”

Speaking on behalf of the host venue, Eric F. Trump said: “We are greatly honoured to host the DP World Tour’s Nexo Championship at Trump International, Scotland – home of the greatest 36 holes in world golf. This is the second consecutive year we have hosted this prestigious event, and I am immensely proud of the two championships link courses that we have built along the spectacular North Sea shoreline. It is testament to their quality and stature that both the Old Course and New Course will host world-class tournaments this August.”

Don Trump Jr. also commented on the renewal of the Nexo Championship: “2026 is set to be another incredible year for championship golf at Trump International, Scotland. A huge thank you to the title sponsor Nexo and all those committed to delivering this great event.”

As a tournament, the Nexo Championship first appeared on the Race to Dubai in 2020 as the Scottish Championship. Its evolution into a named Nexo staple reflects both the DP World Tour’s growing sponsorship ambitions and Nexo’s broader mission for consistent, long-term, and purposeful title partnerships at historically significant events – the most effective tools for building lasting brand recognition in premium markets.

At last year’s Nexo Championship, Scotland’s Grant Forrest claimed his second DP World Tour title, finishing eight under par and four strokes clear of England’s Joe Dean. Forrest also collected a $10,000 bonus as the inaugural winner of the Course Record presented by Nexo, set during a second-round 66. The 2026 edition will introduce a celebrity pro-am on Wednesday, August 19, broadening the tournament’s appeal beyond solely the professional field.

The Nexo Championship renewal is one expression of a deliberate, long-term approach to sport that Nexo is building across disciplines and continents. As Official Partner of the Audi Revolut Formula 1 Team, Official Crypto Partner of the Australian Open, title partner of the ATP 500 Dallas Open, and Official Regional Digital Asset Partner of the Argentine National Football Team ahead of the 2026 FIFA World Cup, Nexo has constructed a portfolio designed for compounding returns – recurring, premium exposure and experiences for the financially active, globally mobile audiences it serves.

About Nexo

Nexo is a premier digital assets wealth platform designed to empower clients to grow, manage, and preserve their crypto holdings. Our mission is to lead the next generation of wealth creation by focusing on customer success and delivering tailored solutions that build enduring value, supported by 24/7 client care.

Since 2018, Nexo has provided unmatched opportunities to forward-thinking clients in over 199+ jurisdictions. With over $430 billion processed globally, we bring lasting value to millions worldwide. Built on deep industry expertise, a sustainable business model, robust infrastructure, stringent security, Nexo champions innovation and long-lasting prosperity.

Official website: nexo.com

About the DP World Tour

The DP World Tour is the main men’s professional golf tour of the European Tour group. As golf’s global tour, we showcase global talent in global destinations and use our platform to build, entertain and connect our global community.

GLOBAL TALENT: We provide pathways and a platform for the leading international talent, bringing together golfing icons, national heroes and emerging stars from around the world.

GLOBAL DESTINATIONS: We stage tournaments in iconic cities and locations around the world and each week we celebrate and showcase the rich diversity of the courses, cities and cultures we visit.

GLOBAL COMMUNITY: We build, entertain and connect communities through our commitment to innovation, creative content and having a positive social and environmental impact.

Our 2026 Global Schedule features 42 tournaments in 25 different countries and comprises three distinct phases: five ‘Global Swings’, the ‘Back 9’ and the ‘DP World Tour Play-Offs’. It features five Rolex Series events – the premium category of events on the DP World Tour – and four Major Championships, all of which count towards the Race to Dubai Rankings, the Tour’s season-long competition which concludes at the DP World Tour Championship in Dubai.

DP World, the leading provider of global smart end-to-end supply chain and logistics solutions, has been the title partner of the DP World Tour since the start of the 2022 season, the Tour’s 50th season following its formation in 1972. We also enjoy the support of many of the world’s leading business brands with DP World, Rolex, Aldar, AWS, BMW, Buffalo Trace Distillery, Emirates, Fortinet, HCLTech, Husqvarna, Michelob ULTRA, Nexo and Vestas as Official Partners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260520684059/en/

Permalink
https://www.aetoswire.com/en/news/2005202655196

Contacts
Media Contacts
Nexo Communications team | communications@nexo.com
DP World Tour Communications | Caitlin Nobes, cnobes@etghq.com

PREVIOUS POST

1GLOBAL Launches Verint Communications Analytics to Enhance Cloud Compliance for Financial and Regulated Industries

africa-live — Thu, 21 May 2026 06:37:31 GMT

AMSTERDAM - Wednesday, 20. May 2026 1GLOBAL now offers transcription with insights into mobile calls in 10 countries on Verint Communications Analytics, built specifically for financial markets and trading environments Streamlines the compliance investigation and mobile call monitoring process through transcription and analysis Supports transcription and translation from 30+ languages into English with near real-time processing (BUSINESS WIRE) -- 1GLOBAL, a pioneer in global telecommunications solutions, today announced its launch of Verint® Communications Analytics, a key offering within Verint Financial Compliance (VFC) providing mobile call transcription and analytics capabilities. Verint Communications Analytics has been designed to help financial institutions and regulated organizations accelerate productivity when monitoring voice calls (including mobile), identifying behavioral patterns, querying data intentionally by topic, risks, keywords or sentiment, identifying misuse and reducing regulatory risk. Verint Communications Analytics is seamlessly integrated into 1GLOBAL’s mobile platform across 10 international markets. It enables cloud compliance customers to achieve faster and more efficient results via transcription and various analytics. Transforming Raw Data into Actionable and Valuable Intelligence As regulatory scrutiny intensifies, financial firms face growing pressure to monitor communications more comprehensively, yet many still rely on fragmented recording tools and a time-consuming manual review process. 1GLOBAL’s use of Verint Communications Analytics fundamentally addresses this challenge by transforming compliance from a reactive obligation into a proactive intelligence function. The 1GLOBAL Cloud Compliance Platform records all mobile calls and SMS and securely transfers them to Verint Communications Analytics for automated transcription, summarization, sentiment analysis, and multilingual topic detection – translating from 30+ languages into English with near real-time processing. This allows compliance teams working in financial institutions and regulated industries to identify risks faster and investigate potential issues in days rather than weeks, completely securely. 1GLOBAL’s entire architecture is deployed in multiple regions, including EMEA (Europe, Middle East and Africa) and North America, ensuring that call media is always processed locally within the customer’s regulatory jurisdiction and never transferred across regions. This is why 1GLOBAL Compliance is trusted by regulated financial institutions, including eight of the world’s top ten investment banks. Siobhan Thompson, Head of Sales, 1GLOBAL Compliance, said: “In today’s regulatory environment, firms need confidence that business communications are being captured accurately and reviewed efficiently. By combining Verint Communications Analytics with our global mobile recording capabilities, we help compliance teams identify potential risks faster, reduce operational burden, and strengthen oversight across regulated communications.” John Bourne, SVP Global Channels and Alliances, Verint, said: “Extending Verint Communications Analytics to 1GLOBAL’s mobile network marks an important step in how regulated firms can apply AI to voice data at a global scale. Together we are equipping compliance and risk teams with a unified view across mobile communications, helping them move from sampling and spot checks to continuous, intelligent oversight.” About 1GLOBAL: Leading Digital Transformation in Telecommunications 1GLOBAL is a technology-driven global mobile communications provider dedicated to empowering enterprises worldwide to unlock the full growth potential of mobile connectivity. With a best-in-class telecom technology platform, a comprehensive suite of globally viable regulatory licenses, and privileged access to the telecom wholesale market, 1GLOBAL is uniquely positioned to deliver seamless mobile connectivity solutions. Serving the world’s leading banks, corporations, and digital-first businesses—including neo-banks, travel companies, and retail groups—1GLOBAL connects over 60 million devices globally. In 2025, 1GLOBAL continued to grow profitably, generating revenue of USD 203 million and a profit of USD 26 million. The year was characterized by strong demand for the 1G Connect Travel™ offering, the expansion of enterprise and compliance solutions, and continued investment in eSIM technology. Going forward, 1GLOBAL will focus on expanding national connectivity, extending its MVNO footprint and scaling its technology platform to continue delivering sustainable, profitable growth. Established in 2022 by experienced tech founders and entrepreneurs Hakan Koç and Pyrros Koussios, 1GLOBAL is a European technology leader driving digital transformation in the global telecommunications market. It operates as a fully regulated Mobile Virtual Network Operator (“MVNO”) in 12 countries and as a regulated telecommunications operator in an additional 28 countries. Headquartered in the Netherlands, with world-class R&D hubs in Lisbon, Berlin, and São Paulo, 1GLOBAL employs close to 500 experts across 15 countries. View source version on businesswire.com: https://www.businesswire.com/news/home/20260520420998/en/ Permalink https://www.aetoswire.com/en/news/2005202655193 Contacts Contact 1GLOBAL 1GLOBAL Communications Email: press@1global.com www.1global.com

Chiesi Group Announces New Chair and Vice Chair

africa-live — Thu, 21 May 2026 05:50:37 GMT

PARMA, Italy -
Highlights:

Planned transition in the Chair and Vice Chair roles reflects the Chiesi family’s long-term commitment to continuity, shared value and responsible governance across generations
Maria Paola Chiesi is appointed Chair, the first woman in this role; aims to reinforce sustainability as an integral and enduring pillar of the Group’s strategy

(BUSINESS WIRE) -- Chiesi today announced a planned leadership change in its Board of Directors: Maria Paola Chiesi has been appointed Chair of the Board, succeeding Alessandro Chiesi, who is completing his tenure after nearly three years in the role, and will now continue to serve as Vice Chair.

During his mandate, Alessandro Chiesi oversaw the Group through a phase of continued international development and governance strengthening, thereby further consolidating Chiesi’s long-term strategy as a research focused biopharmaceutical company and certified B Corp.

“It has been my privilege to serve as Chair during a period of evolution for Chiesi,” said Alessandro Chiesi. “What has remained unchanged is the Group’s firm roots in our clear values, strong sense of responsibility, and long-term vision. On behalf of the Board and personally, I congratulate Maria Paola on her appointment and offer her our collective support. I am honored to assume the Vice Chair role, and I will continue working to support Chiesi in advancing its stated objectives.”

The Board has unanimously appointed Maria Paola Chiesi as Chair, effective immediately. As a member of the Chiesi family and Board, and through her operational roles over the last 30 years, she has played a central role in shaping the Group’s strategic planning and in embedding sustainability as a core driver of business decisions. This appointment also marks an important milestone in the Group’s history, as she becomes the first woman Chair of Chiesi.

“I take on this new role with a deep sense of accountability, and with the aim to reinforce our continuity and commitment to the values that have guided Chiesi through generations,” said Maria Paola Chiesi. “For us, science that cares means pursuing scientific innovation with responsibility for its impact on people, society and the environment. As ever, this principle underpins our identity as a Benefit Corporation and B Corp, and it makes sustainability an integral part of our business model, embedded in how we make decisions and create long-term value for patients, communities and future generations.”

This transition reflects the Board’s intention to maintain stability and coherence in governance, while continuing to align growth, innovation, and sustainability through a long-term, multigenerational perspective.

About Chiesi Group

Chiesi is a research-oriented international biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment.

By adopting the legal form of Benefit Corporation in Italy, the US, France and Colombia, Chiesi’s commitment to creating shared value for society as a whole is legally binding and central to company-wide decision-making. As a certified B Corp since 2019, Chiesi is part of a global community of businesses that meet verified standards of social and environmental impact. The company aims to reach Net-Zero greenhouse gases (GHG) emissions by 2035.

With 90 years of experience, Chiesi is headquartered in Parma (Italy), with 31 affiliates worldwide, and counts more than 7,900 employees. The Group’s research and development centre in Parma works alongside 6 other important R&D hubs in France, the US, Canada, China, the UK, and Sweden.

For further information please visit www.chiesi.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20260520447292/en/

Permalink
https://aetoswire.com/en/news/2005202655187

Contacts
Press Info:
Anna Bonisoli Alquati, Head of Global External Communications: mediarelations@chiesi.com
Michela Lijoi, Global External Communications Sr. Manager: mobile +39 328.6353044, e-mail: m.lijoi@chiesi.com
Davide Paterlini, Global External Communications Sr. Manager: mobile +39 345.7983132, e-mail: d.paterlini@chiesi.com

The LYCRA Company to Successfully Complete Comprehensive Financial Restructuring

africa-live — Wed, 20 May 2026 16:47:15 GMT

WILMINGTON, Del. - Wednesday, 20. May 2026 Company positioned for long-term growth, operational excellence, and continued customer-focused innovation Will emerge from financial restructuring with enhanced financial flexibility and significantly less debt New ownership and Board of Directors committed to executing on vision to take the business to the next level Bruce Rubin appointed Executive Chairman and Dean Williams appointed Interim Chief Executive Officer (BUSINESS WIRE)--The LYCRA Company, LLC (“the Company”), a global leader in developing fiber and technology solutions for the apparel and personal care industries, will successfully complete its comprehensive financial restructuring process and emerge from Chapter 11 protection on May 20, 2026. The LYCRA Company has established a durable capital structure that will enable the Company’s pursuit of its growth strategy through investment in innovation, customer partnerships, and global operations. The Company will emerge from its comprehensive restructuring process with significantly enhanced financial flexibility and a strengthened balance sheet to support long-term growth. The Company will have reduced its total long-term debt by more than $1.2 billion and will obtain more than $75 million in new money investment. Throughout the process, the Company has maintained uninterrupted operations and continues to deliver on commitments to its employees, customers, and vendors. The LYCRA Company will be supported by new equity owners. The new owners are investment funds with a global presence that have been long-term investors in the Company’s securities. Collectively, they bring deep experience and commitment to the Company, its products, and its brands, and are committed to building on the positive momentum of the restructuring process by investing in the Company’s future success. Dean Williams, the Company’s Chief Financial Officer, has been appointed interim Chief Executive Officer. Mr. Williams will serve in an interim capacity while a search is conducted for a permanent CEO. Mr. Williams has been with the Company since its formation over seven years ago and has extensive experience in financial leadership, strategic planning, and operational management, positioning him very well to guide The LYCRA Company through this next phase. Gary Smith, the Company’s former Chief Executive Officer, has stepped down and separated from the Company. The Company has also appointed a new Board of Directors, with Bruce Rubin, an experienced energy and chemicals executive with over 45 years of leadership experience, serving as Executive Chairman of the Board. Mr. Rubin stated, “With a strong foundation in place, The LYCRA Company will be well-positioned to enhance operational excellence, accelerate innovation, deepen customer partnerships, and reinvest in our high-quality products. We look forward to growing our distinct and trusted brands into the future. We would like to thank Gary and the departing Board for their steady leadership in guiding the Company through this pivotal period. The Board looks forward to working closely with Dean – an exceptional and trusted operational leader – as we position the Company for success.” The rest of The LYCRA Company's executive leadership team remains in place and will continue to partner closely with Dean and other key stakeholders to accelerate the Company’s path forward. “Emergence marks a defining moment for The LYCRA Company,” said Dean Williams, Interim Chief Executive Officer. “We will now be a financially stronger, more focused organization that is positioned for growth. This milestone would not have been possible without our team members, whose resilience, dedication, and commitment to our customers enabled us to navigate this process without disruption. While we still have work to do to reach our full potential, we have never been better positioned to do so.” The LYCRA Company is advised in this matter by Linklaters LLP and Haynes Boone, LLP as legal counsel, Houlihan Lokey as investment banker, and FTI Consulting as financial and communications advisor. About The LYCRA Company The LYCRA Company innovates and produces fiber and technology solutions for the apparel and personal care industries and owns the leading consumer brands: LYCRA®, LYCRA HyFit®, LYCRA® T400®, COOLMAX®, THERMOLITE®, ELASPAN®, SUPPLEX® and TACTEL®. Headquartered in Wilmington, Delaware, U.S., The LYCRA Company is recognized worldwide for its sustainable products, technical expertise, and marketing support. The LYCRA Company focuses on adding value to its customers’ products by developing unique innovations designed to meet the consumer’s need for comfort and lasting performance. Learn more at thelycracompany.com. LYCRA® is a trademark of The LYCRA Company. Forward-Looking Statements This press release contains statements that are not historical information and are "forward-looking statements." Forward-looking statements give current expectations or forecasts of future events and are not guarantees of future performance. Statements can generally be identified as forward looking because they include words such as "believes," "anticipates," "expects," "intends," "plans," "will," "estimates," "potential," "target," "predict," "project," "seek," and variations thereof or "could," "should" or words of similar meaning. Statements that describe the Company's future plans, objectives or goals are also forward-looking statements, which reflect the current views of the Company with respect to future events and are subject to assumptions, risks and uncertainties that could cause actual results to differ materially. Although the Company believes that these forward-looking statements are based upon reasonable assumptions regarding, among other things, the economy, its knowledge of its business, and key performance indicators that impact the Company, these forward-looking statements involve risks, uncertainties and other factors that may cause actual results to differ materially from those expressed in or implied by the forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except to the extent required by applicable law or regulation, the Company undertakes no obligation to update these forward-looking statements to reflect future events or circumstances or to reflect the occurrence of unanticipated events. You should consider these factors carefully in evaluating forward-looking statements and are cautioned not to place undue reliance on such statements. View source version on businesswire.com: https://www.businesswire.com/news/home/20260518617195/en/ Permalink https://www.aetoswire.com/en/news/2005202655173 Contacts Media Rachel Chesley / Misha Ross LYCRAcomms@fticonsulting.com

Johns Manville Announces John Vasuta as New CEO

africa-live — Wed, 20 May 2026 14:53:28 GMT

(BUSINESS WIRE)--Johns Manville (JM), a global building and specialty products manufacturer and a Berkshire Hathaway company, announced today that Bob Wamboldt will retire and John Vasuta will assume the role of President and Chief Executive Officer, effective August 1, 2026.

Vasuta joined Johns Manville in 2019 as President of the company’s Engineered Products business. He also serves on the Board of Directors for EJ, a global leader and private manufacturer of infrastructure access products for water, sewer, utilities, drainage and telecommunications.

“It’s an extraordinary privilege to step into the role of CEO,” Vasuta said. “I’m deeply honored to continue serving our customers and supporting the employees whose dedication makes our success possible.”

Before joining JM, John held leadership roles at Bridgestone Corp., including President of Firestone Building Products International and Senior Vice President of Global Sales, Marketing & Operations, among others. He holds a bachelor’s degree in Engineering, an MBA and a Juris Doctor from the University of Akron.

John’s proven leadership, industry expertise, and strong relationships with both customers and employees make him exceptionally well‑suited to lead JM into the future. He will continue to build on the company’s 168-year history by delivering positive and powerful experiences for employees, customers, owners and other stakeholders.

“I am incredibly proud of what we’ve accomplished together, achieving milestones that reflect the hard work and dedication of our entire organization,” Wamboldt said. “As I step into retirement, I have absolute confidence in John, whose leadership will guide the company to even greater success.”

Wamboldt joined Johns Manville in 2003 and went on to lead each of the company’s three businesses – Engineered Products, Roofing Systems and Insulation Systems – before being named President and CEO in 2020.

“During Bob’s tenure, the company achieved significant progress, and we appreciate the dedication and professionalism he brought to the role of CEO,” said Mary Rhinehart, Chair of Johns Manville. “We congratulate him on a well‑earned retirement and look forward to John continuing to build on this strong foundation for the future.”

About Johns Manville

Johns Manville (JM), a Berkshire Hathaway company (NYSE: BRK.A, BRK.B), is a leading manufacturer and marketer of premium-quality products for building insulation, mechanical insulation, industrial insulation, commercial roofing and roof insulation, as well as fibers and nonwovens for commercial, industrial and residential applications. In business since 1858, the Denver-based company has annual sales of over $4 billion and holds leadership positions in all of its key markets. JM employs nearly 8,000 people and operates in 43 North American and European locations. Additional information can be found at www.jm.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260519630814/en/

Permalink
https://www.aetoswire.com/en/news/2005202655172

Contacts
Media contact:
Eric Brown
eric.brown@jm.com
303-809-2853

Andersen Global Strengthens Global Mobility Capabilities with Collaborating Firm Graebel

africa-live — Wed, 20 May 2026 09:13:27 GMT

(BUSINESS WIRE) -- Andersen Global continues to enhance its multi-dimensional platform through a Collaboration Agreement with Graebel, a global leader in workforce mobility and managed services headquartered in the U.S. with global capabilities spanning the Americas, Europe, and Asia.

Founded in 1950, Graebel works with many of the world’s most recognized organizations to simplify the movement and management of talent. The company helps organizations support employees throughout the workforce journey—from internships and onboarding to domestic and international mobility and career transitions—through services that span strategic planning, departure and destination support, on-assignment assistance, repatriation, and mobility program design. Through strategic advisory and intelligent technology, Graebel enables organizations to make more informed decisions and align talent mobility with broader business and workforce strategies through data-driven insights and deep mobility and governance expertise.

“Our history as a family-owned company has shaped how we approach client relationships, but our focus remains on delivering results,” said Ron Dunlap, CEO of Graebel. “Our collaboration with Andersen Global enhances our ability to support clients with workforce mobility solutions that are efficient, responsive, and designed to address increasingly complex talent and workforce needs.”

“Workforce mobility has become a defining factor for organizations operating across borders,” said Mark L. Vorsatz, global chairman and CEO of Andersen. “Graebel’s long-standing commitment to people, combined with their experience supporting complex workforce mobility programs, complements our existing capabilities. This collaboration enhances our ability to support clients as they manage talent movement in an increasingly global and interconnected business environment.”

Andersen Global is an international association of legally separate, independent member firms comprised of tax, legal, and valuation professionals around the world. Established in 2013 by U.S. member firm Andersen Tax LLC, Andersen Global now has more than 50,000 professionals worldwide and a presence in over 1,000 locations through its member firms and collaborating firms.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260519509360/en/

Permalink

https://www.aetoswire.com/en/news/1905202655165

Contacts

Megan Tsuei

Andersen Global

415-764-2700

InterSystems IntelliCare Becomes the First AI-Native EHR to Achieve EU Medical Device Regulation Certification

africanewsline — Wed, 20 May 2026 08:54:14 GMT

BOSTON - Tuesday, 19. May 2026 AETOSWire Print Regulatory milestone reaffirms InterSystems as a leading provider of enterprise-grade AI applications (BUSINESS WIRE) -- InterSystems, a creative data technology provider powering more than one billion health records globally, today announced that its electronic health record (EHR) solutions have been certified as Class IIa Medical Devices under Regulation (MDR) certification under Regulation (EU) 2017/745. This approval marks the first fully unified AI-native EHR to achieve MDR Class IIa certification in the European Union. This certification demonstrates that InterSystems AI-native EHR meets stringent EU safety and quality standards. This key milestone has significant implications for how healthcare organizations can responsibly scale AI while building confidence among healthcare providers and regulators. InterSystems has secured MDR certification for InterSystems IntelliCare™, a next-generation EHR architected with native artificial intelligence capabilities, and InterSystems TrakCare®, a unified healthcare information system used by leading healthcare systems globally. Built on TrakCare's proven interoperability foundation, InterSystems IntelliCare differentiates itself by delivering AI capabilities that are fundamentally designed into the platform's data layer, rather than bolted on as third-party applications. “Healthcare organizations are rightfully demanding that AI be more than just an experimental add-on,” said Don Woodlock, President, InterSystems. “By securing the EU’s first MDR certification for an AI-native EHR, we are establishing a standard that AI should be at the core of all healthcare applications.” By moving beyond fragmented AI add-ons, InterSystems IntelliCare provides organizations with simplified oversight for their own governance, and clinicians with tools designed to reduce workload and burnout. The platform delivers instant patient summaries, AI‑driven clinical documentation, full chat experiences and intelligent workflows that maintain a critical "human-in-the-loop" safeguard. Features such as ambient clinical orchestration automatically capture, structure and save clinical data in real-time and suggest clinical documentation and orders for clinician approval. InterSystems IntelliCare also seamlessly connects with existing health IT infrastructures, leveraging InterSystems deep history in integration and data management capabilities. About InterSystems InterSystems, a creative data technology provider, delivers a unified foundation for next-generation applications for healthcare, finance, manufacturing, and supply chain customers in more than 80 countries. Our data platforms solve interoperability, speed, and scalability problems for large organizations around the globe to unlock the power of data and allow people to perceive data in imaginative ways. Established in 1978, InterSystems is committed to excellence through its award-winning, 24×7 support for customers and partners around the world. Privately held and headquartered in Boston, Massachusetts, InterSystems has 38 offices in 28 countries worldwide. For more information, please visit InterSystems.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20260519124986/en/ Permalink https://www.aetoswire.com/en/news/1905202655158 Contacts InterSystems PR Contact: Zach Keating pr@intersystems.com 617-551-5158